AFQ056 for Language Learning in Children With FXS

NCT02920892 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Fragile X Syndrome

Interventions

DRUG: AFQ056
DRUG: Placebo
OTHER: Language Intervention

Sponsor

Elizabeth Berry-Kravis

Collaborators

[object Object]
[object Object]